Independent, single-name equity research for the buy-side. Full models, sensitivity tables, and the non-consensus call, updated as the story develops.
Deep research on a few names at a time with a clear view and price target. No maintenance ratings, no hedging. The call and the reasoning behind it.
Every report shows the full analysis. The goal is an honest read on the business, not a model reverse-engineered to hit a number, with convenient assumptions added just to make it work.
Grounded in the same market data that powers Akyla's charting terminal, and refreshed as the thesis develops quarter to quarter.
High-conviction. One name at a time.
Applied Optoelectronics, Inc.
Semiconductors & Related Devices
Transitioning from a loss-making CATV / datacenter optics supplier into a capacity-constrained AI datacenter optics manufacturer.
Latest report
June 9, 2026
Q1 FY26 deep-dive: capacity roadmap to >930k units/yr by YE27, datacenter mix inflection, and a ~$60B implied market cap at $5.0B normalized revenue × 12.0x P/S.
Marvell Technology, Inc.
Semiconductors & Related Devices
Jensen Huang called Marvell "the next trillion-dollar company" (COMPUTEX, Jun 2026); the nearer-term bridge is a revenue story - the FY28 $16.5B / FY29 ~$23B ramp roughly doubles today's ~$244B at a sustained premium multiple.
Latest report
July 7, 2026
Thesis rebuilt as narrative: headwinds and tailwinds up front, then three data-driven deep-dives sourced to the Q1 FY27 call. AI data center is now 76% of revenue ($1.8B, +27% YoY) and accelerating (46% → 50% → 55% segment growth), carrying total revenue to ~$11.5B FY2027 and $16.5B FY2028. Custom silicon ($1.5B FY26 → 20%+ FY27 → doubling FY28 → $10B+ FY29 on a $55B TAM) plus an inflecting connectivity franchise (interconnect >70% YoY, switching past $600M) are the moat GPU vendors don't own. Frames Marvell as the plumbing for every AI cluster - GPU or custom XPU - with ~20-25% of the custom ASIC co-design market and a direct Nvidia partnership (NVLink Fusion, silicon photonics, AI RAN).
Cumberland Pharmaceuticals Inc.
Pharmaceutical Preparations
Signed sale of its entire commercial portfolio to Apotex for $100M cash - above the ~$84M market cap - leaving a cash box plus the retained ifetroban pipeline for free.
Latest report
June 17, 2026
$100M all-cash Apotex asset sale implies ~$6.68/share vs. a $5.62 quote; a sum-of-the-parts special situation gated on the June 24, 2026 shareholder vote, with the retained ifetroban pipeline as free optionality.
Federal National Mortgage Association (Fannie Mae)
Federal and Federally-Sponsored Credit Agencies (6111)
A government-backed mortgage guarantor earning ~$14–17B a year, trapped in conservatorship since 2008 - the bull case is a recapitalization-and-IPO exit at a large multiple of the current price.
Latest report
June 17, 2026
Conservatorship-exit special situation: capital rebuilding toward requirement, Treasury consent rights restored, and a Pershing Square model implying ~$31.81/share (~4x the ~$8.00 quote) - highly asymmetric but policy-dependent.
Micron Technology, Inc.
Semiconductors & Related Devices
Memory has de-commoditized: 16 multi-year take-or-pay Strategic Customer Agreements (~$100B committed, ~$18B cash deposits) and HBM sold out through 2027 reset the earnings base - a path to ~2x as the franchise re-rates.
Latest report
June 28, 2026
FQ3 FY2026 printed record $41.5B revenue and 84.9% gross margin; with ~$98 FY2027 consensus EPS at only ~12x, the path to ~2x ($2,250 / ~$2.6T) comes from re-rating toward a low-20s P/E as the Strategic Customer Agreements prove durable - not heroics.
STMicroelectronics N.V.
Semiconductors & Related Devices
FY2025 was the cyclical trough; AI-datacenter optics/photonics, silicon carbide and a top-ranked microcontroller franchise drive the recovery - long with a path to ~2x as revenue and gross margin re-rate.
Latest report
June 28, 2026
From the ~$11.8B FY2025 bottom, a revenue recovery toward the prior ~$17B peak plus gross-margin normalization underwrites a path to ~2x ($130 / ~$118B), with the AI/silicon-carbide/photonics ramps the swing variable.
Sprouts Farmers Market, Inc.
Retail - Grocery Stores
A premium-grocer compounder hiding inside a soft-comp window: ~10% unit growth, ~26% private-label penetration and self-distribution margin expansion compound EPS - a path to ~2x at a sustained premium multiple.
Latest report
June 28, 2026
Durable new-unit growth plus a comp recovery and operating-margin expansion compound EPS at a mid-teens rate, underwriting a path to ~2x ($156 / ~$14.8B) held at a premium grocer multiple.
Energy Recovery, Inc.
Industrial Machinery & Equipment
The ~98%-share near-monopoly of seawater-desalination energy recovery, sold off on a temporary Middle East delay - the desalination super-cycle and the PX Q650 product cycle drive the recovery.
Latest report
June 28, 2026
A delay-not-cancel GCC megaproject backlog, the PX Q650 cycle into 2028 and ~65% gross margins on net cash underwrite a recovery; we initiate at $14.25 (+~60%), with megaproject conversion and a re-rating charting the path toward a double.
CPS Technologies Corp.
Advanced Materials - Metal-Matrix Composites
A capacity-led turnaround into defense/EV/semiconductor demand for AlSiC metal-matrix composites - the FY2025 swing to GAAP profit is the inflection, with a path to ~2x as capacity scales.
Latest report
June 28, 2026
New-capacity-funded revenue scaling into power-electronics and semiconductor-packaging demand plus margin normalization underwrites a path to ~2x ($9.85 / ~$190M); the Q1 2026 air-pocket and fresh-raise dilution are the named risks.
GlobalFoundries Inc.
Semiconductors & Related Devices
A government-backed ($1.6B CHIPS grant + ~$1.6B loans), defense-accredited specialty foundry re-rating on margin - the Investor-Day path from ~$1.59 to ~$4 EPS by 2028 charts a path to ~2x.
Latest report
June 28, 2026
CHIPS funding, a $3.1B DoD Trusted-Foundry contract and silicon photonics scaling to $1B by 2028 de-risk a gross-margin climb from ~25% to 40%; ~$4 EPS by 2028 at ~20x underwrites a path to ~2x ($150 / ~$82B). Note: 12-month Street consensus sits near today's price - the double is a bull-case bet on 2028 delivery.
POET Technologies Inc.
Semiconductors - Silicon Photonics
Optical-interposer photonics levered to the AI-interconnect boom: the Lumilens ($500M framework) and Foxconn 800G/1.6T wins plus >30k engine shipments in 2026 chart a pre-revenue-to-ramp path to ~2x.
Latest report
June 28, 2026
~$430M cash funds the Malaysia optical-engine ramp; with the EML laser shortage forcing the copper→optics shift, the Lumilens/Foxconn pipeline converting underwrites a path to ~2x ($19.50 / ~$3.4B). Execution-gated; the short-seller report was largely disproven.
LPKF Laser & Electronics SE
Laser Systems - Advanced Packaging
A call option on glass-core substrates: LIDE is the enabling glass-drilling step into the 2028 TSMC/Intel/Samsung CPO-on-glass ramp - North Star margin recovery plus that upside charts a path to ~2x.
Latest report
June 28, 2026
The first LIDE production order (Q1 2026) is the proof point, and the €105–120M 2026 guide excludes any Advanced-Packaging volume - pure upside; North Star margin recovery plus the glass/CPO revenue layer underwrite a path to ~2x (€41.90 / share). Foreign filer (IFRS); financials web-sourced.
Sivers Semiconductors AB
Semiconductors - Photonics & mmWave
The InP laser wedge into the AI-optics light-source shortage: Sivers sells exactly the external light source that co-packaged and linear-pluggable optics are short of - a Photonics-led ramp charts a path to ~2x.
Latest report
June 28, 2026
The O-Net/Enablence ELS module, a GlobalFoundries silicon-photonics collaboration and a $799M pipeline underwrite a Photonics ramp to ~SEK 950m by FY2027E - a path to ~2x (SEK 126 / share). Thin cash and serial dilution are the named risks; foreign filer, financials web-sourced.
Kraken Robotics Inc.
Marine & Subsea Robotics (Defense)
Subsea defense robotics at the inflection: NATO 5%-of-GDP, AUKUS UUV programs and the transformational Covelya deal turn Kraken into a ~C$350M+ business - a path to ~2x.
Latest report
June 28, 2026
Standalone >65% growth guidance plus the Covelya acquisition (closing ~Jul 2026; ~C$350M+ combined revenue at 0.8x leverage) into 20%+ CAGR uncrewed-undersea markets underwrites a path to ~2x (C$13 / ~US$9.20). Foreign filer (CAD); financials web-sourced.
The kind of work you'd build yourself if you had the time. Open the numbers, stress the assumptions, and see exactly how the call is constructed.
Our live model portfolio. Holdings and position weights, refreshed daily from the brokerage. Free to view with your email.